002788 鹭燕医药
已收盘 08-21 15:00:00
资讯
新帖
简况
鹭燕医药2026年半年报:营收105.83亿元净利下滑,集采致毛利承压现金流紧张
蓝鲸财经 · 08-19 17:04
鹭燕医药2026年半年报:营收105.83亿元净利下滑,集采致毛利承压现金流紧张
鹭燕医药(002788)2026年中报简析:增收不增利
证券之星 · 08-19 06:09
鹭燕医药(002788)2026年中报简析:增收不增利
鹭燕医药(002788)6月30日股东户数4.95万户,较上期减少28.77%
证券之星 · 08-17
鹭燕医药(002788)6月30日股东户数4.95万户,较上期减少28.77%
鹭燕医药(002788.SZ)发布上半年业绩,归母净利润1.43亿元,同比下降7.46%
智通财经 · 08-17
鹭燕医药(002788.SZ)发布上半年业绩,归母净利润1.43亿元,同比下降7.46%
异动快报:鹭燕医药(002788)7月20日13点36分触及跌停板
证券之星 · 07-20
异动快报:鹭燕医药(002788)7月20日13点36分触及跌停板
7月16日鹭燕医药(002788)龙虎榜数据:机构净卖出2571.31万元(3日),北向资金净卖出261.62万元(3日)
证券之星 · 07-16
7月16日鹭燕医药(002788)龙虎榜数据:机构净卖出2571.31万元(3日),北向资金净卖出261.62万元(3日)
鹭燕医药:公司建立了防范自然灾害应急预案
证券之星 · 07-14
鹭燕医药:公司建立了防范自然灾害应急预案
鹭燕医药:公司将持续规范经营,增强核心竞争力,为股东创造价值
证券之星 · 07-03
鹭燕医药:公司将持续规范经营,增强核心竞争力,为股东创造价值
鹭燕医药(002788)披露2025年年度权益分派实施公告,7月2日股价上涨0.66%
证券之星 · 07-02
鹭燕医药(002788)披露2025年年度权益分派实施公告,7月2日股价上涨0.66%
鹭燕医药(002788)新增【医美】概念
证券之星 · 06-30
鹭燕医药(002788)新增【医美】概念
股市必读:鹭燕医药(002788)6月29日董秘有最新回复
证券之星 · 06-30
股市必读:鹭燕医药(002788)6月29日董秘有最新回复
鹭燕医药:公司将在股东会通过年度分配方案后2个月内完成利润分配
证券之星 · 06-29
鹭燕医药:公司将在股东会通过年度分配方案后2个月内完成利润分配
鹭燕医药:医保直接结算的加速推进,将有效改善医药流通企业的货款结算环境
证券之星 · 06-29
鹭燕医药:医保直接结算的加速推进,将有效改善医药流通企业的货款结算环境
鹭燕医药:公司根据市场实际情况,发挥公司的竞争优势,推动业务发展
证券之星 · 06-29
鹭燕医药:公司根据市场实际情况,发挥公司的竞争优势,推动业务发展
鹭燕医药:公司将持续为上下游客户提供优质服务,提升公司业绩
证券之星 · 06-29
鹭燕医药:公司将持续为上下游客户提供优质服务,提升公司业绩
鹭燕医药:鹭燕现代中药生产项目一期建设已顺利完成
证券之星 · 05-28
鹭燕医药:鹭燕现代中药生产项目一期建设已顺利完成
股市必读:鹭燕医药(002788)5月22日董秘有最新回复
证券之星 · 05-25
股市必读:鹭燕医药(002788)5月22日董秘有最新回复
鹭燕医药:公司2025年度利润分配方案已获通过
证券之星 · 05-13
鹭燕医药:公司2025年度利润分配方案已获通过
股市必读:鹭燕医药(002788)4月24日披露最新机构调研信息
证券之星 · 04-27
股市必读:鹭燕医药(002788)4月24日披露最新机构调研信息
股市必读:鹭燕医药年报 - 第四季度单季净利润同比下降30.67%
证券之星 · 04-22
股市必读:鹭燕医药年报 - 第四季度单季净利润同比下降30.67%
加载更多
公司概况
公司名称:
鹭燕医药股份有限公司
所属行业:
批发业
上市日期:
2016-02-18
主营业务:
鹭燕医药股份有限公司的主营业务是药品、中药饮片、医疗器械等产品的分销业务以及医药零售连锁业务。公司的主要产品是药品、医疗器械、中药饮片。公司自成立以来,不断提升品牌价值,致力于为客户及上游供应商提供优质的服务,得到客户和行业的广泛认同,在行业中享有较高的商誉和知名度,“鹭燕”和“燕来福”获得厦门市著名商标、福建省著名商标等荣誉。
发行价格:
18.65
{"stockData":{"symbol":"002788","market":"SZ","secType":"STK","nameCN":"鹭燕医药","latestPrice":10.92,"timestamp":1787295798000,"preClose":11.43,"halted":0,"volume":14966379,"delay":0,"changeRate":-0.0446,"floatShares":382000000,"shares":389000000,"eps":0.6934,"marketStatus":"已收盘","change":-0.51,"latestTime":"08-21 15:00:00","open":11.35,"high":11.39,"low":10.83,"amount":165000000,"amplitude":0.049,"askPrice":10.92,"askSize":98,"bidPrice":10.91,"bidSize":318,"shortable":0,"etf":0,"ttmEps":0.6934,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":5,"adr":0,"adjPreClose":11.43,"symbolType":"stock","openAndCloseTimeList":[[1787275800000,1787283000000],[1787288400000,1787295600000]],"highLimit":12.57,"lowLimit":10.29,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":388516736,"isCdr":false,"pbRate":1.34,"roa":"--","peRate":15.748486,"roe":"4.26%","epsLYR":0.72,"committee":0.031453,"marketValue":4243000000,"turnoverRate":0.0392,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-08-24。","floatMarketCap":4170000000},"requestUrl":"/m/hq/s/002788/","defaultTab":"news","newsList":[{"id":"2660446796","title":"鹭燕医药2026年半年报:营收105.83亿元净利下滑,集采致毛利承压现金流紧张","url":"https://stock-news.laohu8.com/highlight/detail?id=2660446796","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660446796?lang=zh_cn&edition=full","pubTime":"2026-08-19 17:04","pubTimestamp":1787130275,"startTime":"0","endTime":"0","summary":"2026年半年度,公司实现营业收入105.83亿元,同比增长1.75%;归属于上市公司股东的净利润为1.43亿元,较上年同期下降7.46%。扣除非经常性损益后的净利润为1.38亿元,同比下降9.88%。受此影响,公司毛利率由上年同期的约7.10%降至6.84%,毛利空间持续压缩。然而,经营性现金流的净流出状态,结合公司较高的资产负债率,凸显了资金周转的压力。报告期末,公司资产负债率维持在74.77%的高位,短期借款达44.30亿元,反映了较大的偿债压力。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1787120025670551573","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["SPHQ","159399","002788"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660497044","title":"鹭燕医药(002788)2026年中报简析:增收不增利","url":"https://stock-news.laohu8.com/highlight/detail?id=2660497044","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660497044?lang=zh_cn&edition=full","pubTime":"2026-08-19 06:09","pubTimestamp":1787090952,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期鹭燕医药发布2026年中报。根据财报显示,鹭燕医药增收不增利。截至本报告期末,公司营业总收入105.83亿元,同比上升1.75%,归母净利润1.43亿元,同比下降7.46%。筹资活动产生的现金流量净额变动幅度为358.86%,原因:银行借款增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900004104.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002788","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660648622","title":"鹭燕医药(002788)6月30日股东户数4.95万户,较上期减少28.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660648622","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660648622?lang=zh_cn&edition=full","pubTime":"2026-08-17 17:37","pubTimestamp":1786959436,"startTime":"0","endTime":"0","summary":"证券之星消息,近日鹭燕医药披露,截至2026年6月30日公司股东户数为4.95万户,较3月31日减少2.0万户,减幅为28.77%。在医药商业行业个股中,鹭燕医药股东户数高于行业平均水平,截至6月30日,医药商业行业平均股东户数为4.65万户。从股价来看,2026年3月31日至2026年6月30日,鹭燕医药区间跌幅为37.97%,在此期间股东户数减少2.0万户,减幅为28.77%。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700023271.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","002788"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660469488","title":"鹭燕医药(002788.SZ)发布上半年业绩,归母净利润1.43亿元,同比下降7.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660469488","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660469488?lang=zh_cn&edition=full","pubTime":"2026-08-17 15:59","pubTimestamp":1786953584,"startTime":"0","endTime":"0","summary":"智通财经APP讯,鹭燕医药 发布2026年半年度报告,报告期内,公司实现营业收入105.83亿元,同比增长1.75%。实现归属于上市公司股东的净利润1.43亿元,同比下降7.46%。基本每股收益0.37元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1480704.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002788"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652262750","title":"异动快报:鹭燕医药(002788)7月20日13点36分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2652262750","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652262750?lang=zh_cn&edition=full","pubTime":"2026-07-20 13:42","pubTimestamp":1784526120,"startTime":"0","endTime":"0","summary":"证券之星7月20日盘中消息,13点36分鹭燕医药(002788)触及跌停板。其所属行业医药商业目前下跌。领涨股为漱玉平民。该股为医药商业,医药,中药概念热股。7月17日的资金流向数据方面,主力资金净流出2994.09万元,占总成交额7.91%,游资资金净流入477.07万元,占总成交额1.26%,散户资金净流入2517.01万元,占总成交额6.65%。近5日资金流向一览见下表:鹭燕医药主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000015908.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002788","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651410471","title":"7月16日鹭燕医药(002788)龙虎榜数据:机构净卖出2571.31万元(3日),北向资金净卖出261.62万元(3日)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651410471","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651410471?lang=zh_cn&edition=full","pubTime":"2026-07-16 17:23","pubTimestamp":1784193796,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年7月16日公布的交易公开信息显示,鹭燕医药因连续三个交易日内,涨幅偏离值累计达到20%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年7月16日收盘,鹭燕医药报收于12.3元,上涨9.82%,换手率16.0%,成交量61.09万手,成交额7.09亿元。从龙虎榜公布的三日买卖数据来看,机构合计净卖出2571.31万元,北向资金合计净卖出261.62万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600028179.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","002788"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651849120","title":"鹭燕医药:公司建立了防范自然灾害应急预案","url":"https://stock-news.laohu8.com/highlight/detail?id=2651849120","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651849120?lang=zh_cn&edition=full","pubTime":"2026-07-14 15:07","pubTimestamp":1784012837,"startTime":"0","endTime":"0","summary":"证券之星消息,鹭燕医药(002788)07月14日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘,超强台风巴威即将在福建登陆,结合近期国内洪涝灾害频发,灾害过后防疫工作对于药品的需求会大大增加,贵公司作为福建省医药流通龙头企业,针对本次台风做好充足的药品供应?鹭燕医药回复:公司建立了防范自然灾害应急预案,并根据预案落实相关举措。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400022748.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","002788"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648345076","title":"鹭燕医药:公司将持续规范经营,增强核心竞争力,为股东创造价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2648345076","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648345076?lang=zh_cn&edition=full","pubTime":"2026-07-03 08:43","pubTimestamp":1783039387,"startTime":"0","endTime":"0","summary":"证券之星消息,鹭燕医药(002788)07月02日在投资者关系平台上答复投资者关心的问题。投资者提问:贵司4月以来股价下跌40%,董事会和管理层有无市值管理计划,经营方面是否有重大负面信息未披露,贵司高管履行职责是否合格?鹭燕医药回复:影响股价短期波动的因素有很多。公司将持续规范经营,增强核心竞争力,为股东创造价值。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070300009172.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002788","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648689316","title":"鹭燕医药(002788)披露2025年年度权益分派实施公告,7月2日股价上涨0.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648689316","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648689316?lang=zh_cn&edition=full","pubTime":"2026-07-02 23:15","pubTimestamp":1783005316,"startTime":"0","endTime":"0","summary":"截至2026年7月2日收盘,鹭燕医药报收于10.69元,较前一交易日上涨0.66%,最新总市值为41.53亿元。近日,鹭燕医药发布《2025年年度权益分派实施公告》。公告显示,公司2025年年度权益分派方案已获2026年5月12日召开的年度股东会审议通过,以公司总股本388,516,736股为基数,向全体股东每10股派发现金红利3.50元(含税),不送红股,不以资本公积金转增股本。本次权益分派股权登记日为2026年7月9日,除权除息日为2026年7月10日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200042837.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002788","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647555027","title":"鹭燕医药(002788)新增【医美】概念","url":"https://stock-news.laohu8.com/highlight/detail?id=2647555027","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647555027?lang=zh_cn&edition=full","pubTime":"2026-06-30 20:30","pubTimestamp":1782822635,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息整理,6月30日鹭燕医药新增概念。鹭燕医药主营业务:药品、中药饮片、医疗器械、疫苗等分销及医药零售连锁。鹭燕医药2026年一季报显示,一季度公司主营收入53.51亿元,同比上升3.43%;归母净利润6793.65万元,同比下降4.75%;扣非净利润6663.38万元,同比下降6.0%;负债率74.59%,投资收益-963.37万元,财务费用4202.55万元,毛利率6.71%。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000043037.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","002788"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647306018","title":"股市必读:鹭燕医药(002788)6月29日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2647306018","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647306018?lang=zh_cn&edition=full","pubTime":"2026-06-30 01:39","pubTimestamp":1782754750,"startTime":"0","endTime":"0","summary":"截至2026年6月29日收盘,鹭燕医药报收于10.41元,上涨3.58%,换手率5.39%,成交量20.57万手,成交额2.11亿元。董秘: 公司将在股东会通过年度分配方案后2个月内完成利润分配。董秘: 公司的经营情况与管理举措请查阅公司2025年年报第三节“管理层讨论与分析”相关内容。当日关注点交易信息汇总:6月29日主力资金净流入838.71万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000001033.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","002788"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647326799","title":"鹭燕医药:公司将在股东会通过年度分配方案后2个月内完成利润分配","url":"https://stock-news.laohu8.com/highlight/detail?id=2647326799","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647326799?lang=zh_cn&edition=full","pubTime":"2026-06-29 15:06","pubTimestamp":1782716796,"startTime":"0","endTime":"0","summary":"证券之星消息,鹭燕医药(002788)06月29日在投资者关系平台上答复投资者关心的问题。投资者提问:公司2025年度利润分配方案已通过,请问具体的分红派息时间安排是怎样的?在当前市场环境下,管理层是否有进一步的市值管理计划或股份回购计划,以向市场传递信心并切实回报投资者?”鹭燕医药回复:公司将在股东会通过年度分配方案后2个月内完成利润分配。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900016757.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","002788"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647326747","title":"鹭燕医药:医保直接结算的加速推进,将有效改善医药流通企业的货款结算环境","url":"https://stock-news.laohu8.com/highlight/detail?id=2647326747","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647326747?lang=zh_cn&edition=full","pubTime":"2026-06-29 15:06","pubTimestamp":1782716795,"startTime":"0","endTime":"0","summary":"证券之星消息,鹭燕医药06月29日在投资者关系平台上答复投资者关心的问题。但在推进期内,也同时存在前期存量账款结算周期拉长的转型期矛盾。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900016756.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK1574","159938","002788","BK1515","09939","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647632679","title":"鹭燕医药:公司根据市场实际情况,发挥公司的竞争优势,推动业务发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2647632679","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647632679?lang=zh_cn&edition=full","pubTime":"2026-06-29 15:06","pubTimestamp":1782716791,"startTime":"0","endTime":"0","summary":"证券之星消息,鹭燕医药(002788)06月29日在投资者关系平台上答复投资者关心的问题。投资者提问:面对中药饮片全国联采带来的行业变革,公司在重点区域的市场开发进度如何?目前销售网络覆盖率和市场份额的提升是否达到了管理层的预期目标?”鹭燕医药回复:公司根据市场实际情况,发挥公司的竞争优势,推动业务发展。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900016753.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","002788"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647283326","title":"鹭燕医药:公司将持续为上下游客户提供优质服务,提升公司业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2647283326","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647283326?lang=zh_cn&edition=full","pubTime":"2026-06-29 15:03","pubTimestamp":1782716596,"startTime":"0","endTime":"0","summary":"证券之星消息,鹭燕医药(002788)06月29日在投资者关系平台上答复投资者关心的问题。投资者提问:随着脑机接口被列为国家重点发展产业链,公司近期获得了相关产品的区域独家配送权。请问目前该业务的实际落地进展如何?未来公司是否会进一步加大对脑机接口等前沿医疗科技领域的投资与业务拓展,以打造新的利润增长极?鹭燕医药回复:公司将持续为上下游客户提供优质服务,提升公司业绩。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900016706.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002788","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638637261","title":"鹭燕医药:鹭燕现代中药生产项目一期建设已顺利完成","url":"https://stock-news.laohu8.com/highlight/detail?id=2638637261","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638637261?lang=zh_cn&edition=full","pubTime":"2026-05-28 08:18","pubTimestamp":1779927485,"startTime":"0","endTime":"0","summary":"证券之星消息,鹭燕医药(002788)05月27日在投资者关系平台上答复投资者关心的问题。投资者提问:你好,请问一下公司现代中药生产项目进展怎么样?鹭燕医药回复:“鹭燕现代中药生产项目”一期建设已顺利完成,子公司亳州市中药饮片厂于 2026 年 1 月 21 日取得新的《药品生产许可证》。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800006175.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002788","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638302826","title":"股市必读:鹭燕医药(002788)5月22日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2638302826","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638302826?lang=zh_cn&edition=full","pubTime":"2026-05-25 02:41","pubTimestamp":1779648070,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘,鹭燕医药报收于12.36元,上涨1.15%,换手率3.35%,成交量12.8万手,成交额1.58亿元。董秘最新回复投资者: 尊敬的董秘您好,近来公司股价大跌,公司是否有触及ST退市的违规行为,管理层是否有减持计划?交易信息汇总资金流向5月22日主力资金净流出721.36万元;游资资金净流出1659.43万元;散户资金净流入2380.79万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500001117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002788","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635065472","title":"鹭燕医药:公司2025年度利润分配方案已获通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2635065472","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2635065472?lang=zh_cn&edition=full","pubTime":"2026-05-13 15:30","pubTimestamp":1778657441,"startTime":"0","endTime":"0","summary":"证券之星消息,鹭燕医药(002788)05月13日在投资者关系平台上答复投资者关心的问题。投资者提问:啥时候分红鹭燕医药回复:公司2026年5月12日召开的2025年年度股东会已审议通过了2025年度公司利润分配方案。公司将按规定,在股东会后2个月内完成利润分配。具体分配时间敬请关注公司公告。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300022296.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002788","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630339051","title":"股市必读:鹭燕医药(002788)4月24日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2630339051","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2630339051?lang=zh_cn&edition=full","pubTime":"2026-04-27 05:33","pubTimestamp":1777239192,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘,鹭燕医药报收于13.79元,下跌2.75%,换手率7.57%,成交量28.9万手,成交额3.98亿元。机构调研要点2025年公司营收同比增长3.79%,归母净利润同比下降18.74%,主要受药品、器械、中药集采政策叠加影响,行业整体毛利率下滑,以量换价未能完全抵消价格下行压力。2025年第四季度归母净利润同比下降30.7%,主要受毛利率下滑、费用增长及信用减值损失增加影响,无明显季度性波动;2026年公司将着力增强核心竞争力,改善业绩表现。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700006266.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","002788"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629513790","title":"股市必读:鹭燕医药年报 - 第四季度单季净利润同比下降30.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629513790","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2629513790?lang=zh_cn&edition=full","pubTime":"2026-04-22 01:34","pubTimestamp":1776792871,"startTime":"0","endTime":"0","summary":"来自股本股东变化:截至2026年3月31日,股东户数环比下降11.99%,户均持股升至5593股,呈现筹码集中趋势。来自业绩披露要点:2025年归母净利润同比下降18.74%,第四季度降幅扩大至30.67%,盈利能力承压。股本股东变化股东户数变动截至2026年3月31日公司股东户数为6.95万户,较12月31日减少9463.0户,减幅为11.99%。公司公告汇总关于2025年度利润分配预案的公告鹭燕医药股份有限公司于2026年4月17日召开第六届董事会第九次会议,审议通过2025年度利润分配预案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042200004030.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002788"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1787339967533,"stockEarnings":[{"period":"1week","weight":-0.0714},{"period":"1month","weight":0.1617},{"period":"3month","weight":-0.0848},{"period":"6month","weight":-0.2616},{"period":"1year","weight":0.2796},{"period":"ytd","weight":-0.4659}],"compareEarnings":[{"period":"1week","weight":-0.0056},{"period":"1month","weight":0.0099},{"period":"3month","weight":-0.0505},{"period":"6month","weight":-0.0433},{"period":"1year","weight":0.0356},{"period":"ytd","weight":-0.016}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"鹭燕医药股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"49481人(较上一季度减少28.77%)","perCapita":"7717股","listingDate":"2016-02-18","address":"福建省厦门市湖里区安岭路1004号","registeredCapital":"38851万元","survey":" 鹭燕医药股份有限公司的主营业务是药品、中药饮片、医疗器械等产品的分销业务以及医药零售连锁业务。公司的主要产品是药品、医疗器械、中药饮片。公司自成立以来,不断提升品牌价值,致力于为客户及上游供应商提供优质的服务,得到客户和行业的广泛认同,在行业中享有较高的商誉和知名度,“鹭燕”和“燕来福”获得厦门市著名商标、福建省著名商标等荣誉。","listedPrice":18.65},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"鹭燕医药(002788)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供鹭燕医药(002788)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"鹭燕医药,002788,鹭燕医药股票,鹭燕医药股票老虎,鹭燕医药股票老虎国际,鹭燕医药行情,鹭燕医药股票行情,鹭燕医药股价,鹭燕医药股市,鹭燕医药股票价格,鹭燕医药股票交易,鹭燕医药股票购买,鹭燕医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"鹭燕医药(002788)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供鹭燕医药(002788)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}